You are hereBlogs / admin's blog / Emerging role of thiamine therapy for prevention and treatment of early stage diabetic nephropathy

Emerging role of thiamine therapy for prevention and treatment of early stage diabetic nephropathy


By admin - Posted on 17 March 2011

Rabbani N, Thornalley PJ. Emerging role of thiamine therapy for prevention and treatment of early stage diabetic nephropathy. Diabetes Obes Metab. 2011 Feb 22. doi: 10.1111/j.1463-1326.2011.01384.x. [Epub ahead of print] PubMed PMID: 21342411

Thiamine supplementation prevented the development of early-stage nephropathy in diabetic rats and reversed increased urinary albumin excretion in patients with type 2 diabetes and microalbuminuria in two recent clinical trials.

http://www.ncbi.nlm.nih.gov/pubmed/21342411

Access to Parenteral Thiamine

Biological Therapies supplies a range of registered injections containing parenteral thiamine.
See the TGA website:  http://www.tga.gov.au/safety/alerts-medicine-ivthiamine-100728.htm
See also the SHPA website:  SHPA Manufacturers Alerts (Thiamine Injection)

Pub Med Highlights